CBRE vs HRMY · P/E 43, rev $21.75B vs P/E 14, rev $476.7M
CBRE Group Inc Class A (CBRE) versus Harmony Biosciences Holdings (HRMY) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Not investment advice. Open the CBRE and HRMY stock pages for the full models.
Not investment advice.